WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001032884) EDUCATIONAL KIT AND METHOD CONTAINING NOVEL ALPHA HELICAL PROTEIN-34
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/032884    International Application No.:    PCT/US2000/029277
Publication Date: 10.05.2001 International Filing Date: 24.10.2000
Chapter 2 Demand Filed:    07.05.2001    
IPC:
C07K 14/52 (2006.01), G09B 23/24 (2006.01)
Applicants: ZYMOGENETICS, INC. [US/US]; 1201 Eastlake Avenue East, Seattle, WA 98102 (US)
Inventors: CONKLIN, Darrell, C.; (US).
TAFT, David, W.; (US)
Agent: LUNN, Paul, G.; ZymoGenetics, Inc., 1201 Eastlake Avenue East, Seattle, WA 98102 (US)
Priority Data:
09/430,153 29.10.1999 US
Title (EN) EDUCATIONAL KIT AND METHOD CONTAINING NOVEL ALPHA HELICAL PROTEIN-34
(FR) KITS ET PROCEDE DIDACTIQUES COMPRENANT UNE NOUVELLE PROTEINE 34 D'HELICE ALPHA
Abstract: front page image
(EN)An educational kit comprised of a novel polypeptide, alpha helical protein-34 (Zalpha34), polynucleotides that encode Zalpha34 and antibodies to Zalpha34. The present invention also relates to polynucleotide and polypeptide molecules for Zalpha34. The polypeptides, and nucleotides encoding them, are hormonal and may be used to promote spermatogenesis. The present invention also includes antibodies to the Zalpha34 polypeptides, which can be used to inhibit spermatogenesis.
(FR)Un kit didactique comprend un nouveau polypeptide, une protéine 34 d'hélice alpha (Zalpha34), des polynucléotides qui codent Zalpha34 et des anticorps dirigés contre Zalpha34. La présente invention concerne également des molécules de polynucléotide et de polypeptide destinées à Zalpha34. Les polypeptides et les nucléotides qui codent ces derniers sont d'origine hormonale et peuvent être utilisés pour favoriser la spermatogenèse. Cette invention concerne également des anticorps dirigés contre les polypeptides Zalpha34, qui peuvent être utilisés pour inhiber la spermatogenèse.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)